DCT

2:26-cv-00289

Omni MedSci Inc v. Oura Health Oy

Log In
Key Events
Amended Complaint
complaint Intelligence

I. Executive Summary and Procedural Information

  • Parties & Counsel:
  • Case Identification: 2:26-cv-00289, E.D. Tex., 04/15/2026
  • Venue Allegations: Plaintiff alleges venue is proper in the Eastern District of Texas because Defendant Ōura, as a foreign entity, may be sued in any judicial district.
  • Core Dispute: Plaintiff alleges that Defendant's Oura Ring smart rings, along with the associated mobile app and cloud platform, infringe four U.S. patents related to the non-invasive optical measurement of physiological parameters.
  • Technical Context: The lawsuit concerns the technology of wearable health-monitoring devices, a significant and growing market segment focused on using optical sensors to track user biometrics.
  • Key Procedural History: The complaint alleges that Defendant had pre-suit knowledge of at least three of the asserted patents. Notice of the '868, '533, and '304 patents is alleged via a prior lawsuit filed by Plaintiff against Samsung. Knowledge of the '533 patent is also alleged through Ōura's own patent prosecution, as an Ōura-owned patent ('725 Patent) allegedly identifies the '533 patent on its face.

Case Timeline

Date Event
2010-01-01 Omni MedSci founded (approximate, based on Compl. ¶20)
2012-12-31 Earliest Priority Date for '868, '533, '304, and '475 Patents
2015-06-16 U.S. Patent No. 9,055,868 Issued
2017-05-16 U.S. Patent No. 9,651,533 Issued
2020-12-29 U.S. Patent No. 10,874,304 Issued
2024-06-18 Ōura's U.S. Patent No. 12,013,725 Issued
2024-12-20 Plaintiff files Original Complaint against Samsung
2025-04-08 U.S. Patent No. 12,268,475 Issued
2025-05-05 Plaintiff alleges Defendant had actual notice of the '475 Patent
2026-04-15 Fourth Amended Complaint Filed

II. Technology and Patent(s)-in-Suit Analysis

U.S. Patent No. 9,055,868 - "System and Method for Voice Control of Medical Devices"

  • Patent Identification: U.S. Patent No. 9,055,868, "System and Method for Voice Control of Medical Devices," issued June 16, 2015.

The Invention Explained

  • Problem Addressed: The patent describes prior art optical diagnostic systems as lacking flexibility and convenience, particularly regarding remote control and enhanced data processing capabilities Compl. ¶31 '868 Patent, col. 1:39-46
  • The Patented Solution: The invention is a system combining an optical measurement device with a separate control system (e.g., a smartphone) that wirelessly receives and transmits physiological data. This control system can accept voice and manual inputs, and it sends the data to a host for storage, processing, and display on remote devices, thereby offering greater flexibility (Compl. ¶31; Compl. ¶32, Compl. ¶¶col. 1:47-2:33).
  • Technical Importance: This approach decouples the sensor from the user interface and processing hub, enabling the use of powerful consumer electronics (like smartphones) to control and analyze data from dedicated medical or physiological sensors.

Key Claims at a Glance

  • The complaint asserts independent claim 7 and dependent claim 9 Compl. ¶74
  • Independent Claim 7 Elements:
    • A light source with semiconductor diodes generating an input light beam.
    • A lens system configured to communicate the light beam onto a part of a user's body comprising blood.
    • A software application on a control system for generating physiological data.
    • The control system having a touch-screen, voice and manual inputs capabilities, circuitry for position information, and a wireless transceiver.
    • A host comprising a digital file for storing wireless data, control logic to process the data and generate a user status, and an output for communicating the status to remote display devices.

U.S. Patent No. 9,651,533 - "Short-Wave Infrared Super-Continuum Lasers for Detecting Counterfeit or Illicit Drugs and Pharmaceutical Process Control"

  • Patent Identification: U.S. Patent No. 9,651,533, "Short-Wave Infrared Super-Continuum Lasers for Detecting Counterfeit or Illicit Drugs and Pharmaceutical Process Control," issued May 16, 2017.

The Invention Explained

  • Problem Addressed: The patent identifies an "unmet need for non-invasive physiological measurement techniques" like glucose monitoring that provide adequate sensitivity, selectivity, and repeatability, which conventional systems allegedly failed to do Compl. ¶41 '533 Patent, col. 3:47-63
  • The Patented Solution: The invention uses wearable devices with brighter light sources in the near-infrared wavelength range to increase the signal from blood constituents. The system includes a personal device (like a smartphone) to receive and process data, which can then be sent to a remote device (like a cloud server) for further processing and storage (Compl. ¶41; Compl. ¶42, Compl. ¶¶col. 5:35-6:3; '533 Patent, Compl. ¶fig. 13).
  • Technical Importance: The invention proposes using specific near-infrared optical properties and system architecture to improve the signal-to-noise ratio for non-invasive physiological measurements.

Key Claims at a Glance

  • The complaint asserts independent claims 11 and 12 Compl. ¶78
  • Independent Claim 11 Elements:
    • A light source (e.g., LEDs) generating an optical beam with wavelengths between 700-2500 nanometers.
    • A plurality of lenses delivering the beam to a sample.
    • A receiver with filters to receive and process a reflected portion of the beam to generate an output signal.
    • A personal device to receive, process, store, and display the output signal.
    • A remote device to receive the wirelessly transmitted signal and process it.
  • Independent Claim 12 adds: The capability to generate the output signal by comparing signals at different optical wavelengths.
  • The complaint does not explicitly reserve the right to assert dependent claims.

U.S. Patent No. 10,874,304 - "Semiconductor Source Based Near Infrared Measurement Device with Improved Signal-to-Noise Ratio"

  • Patent Identification: U.S. Patent No. 10,874,304, "Semiconductor Source Based Near Infrared Measurement Device with Improved Signal-to-Noise Ratio," issued December 29, 2020.
  • Technology Synopsis: The patent describes a system for improving the signal-to-noise ratio of near-infrared measurements. This is achieved by increasing light intensity or by using a differential measurement technique: comparing a signal received when light sources are on with a signal received when they are off to cancel out ambient light noise Compl. ¶53 '304 Patent, abstract
  • Asserted Claims: Claims 12 and 13 Compl. ¶89
  • Accused Features: The complaint alleges that Ōura's system, comprising the ring, smartphone app, and cloud platform, infringes by using a light source, receiver, and signal processing techniques to improve signal-to-noise ratio in non-invasive measurements Compl. ¶¶52-54

U.S. Patent No. 12,268,475 - "Wearable Device for Differential Measurement on Pulse Rate and Blood Flow"

  • Patent Identification: U.S. Patent No. 12,268,475, "Wearable Device for Differential Measurement on Pulse Rate and Blood Flow," issued April 8, 2025.
  • Technology Synopsis: The patent is directed to a wearable apparatus for physiological monitoring. It discloses improving signal-to-noise ratio by comparing signals generated when light sources are on versus off, synchronizing the detection system with the light source, and modulating the light source Compl. ¶64 The claims also cover specific arrangements of LEDs and detectors along an arc Compl. ¶65
  • Asserted Claims: Claims 1, 5-8, and 11-13 Compl. ¶101
  • Accused Features: The complaint accuses Ōura's smart rings of infringing through their use of light-emitting diodes, optical detectors, processors, and communication with a smartphone, along with specific signal processing techniques to improve measurement accuracy Compl. ¶¶63-65

III. The Accused Instrumentality

  • Product Identification: The accused systems consist of the Ōura Ring (Gen 1, Gen 2, Gen 3, and Gen 4 series), the companion Ōura mobile application for iOS and Android, and the Ōura Cloud computing platform Compl. ¶¶70-71
  • Functionality and Market Context: The Ōura Ring is a wearable device worn on a finger to measure physiological parameters such as heartbeat and blood oxygen level Compl. ¶70 Compl. ¶72 The ring is designed to transfer this data to a smartphone or tablet running the Ōura app. The system is further capable of transferring this information to the Ōura Cloud for storage and processing Compl. ¶72 The complaint frames these components as an "integrated diagnostic system" that Ōura actively markets and supports Compl. ¶70 Compl. ¶74

No probative visual evidence provided in complaint.

IV. Analysis of Infringement Allegations

9,055,868 Infringement Allegations

Claim Element (from Independent Claim 7) Alleged Infringing Functionality Complaint Citation Patent Citation
a light source comprising one or more semiconductor diodes generating an input light beam... The Ōura Ring products contain hardware components, including light sources, for measuring physiological parameters. ¶72 col. 4:18-20
a lens system configured to communicate a portion of the input light beam onto a part of a user's body comprising blood... The Ōura Ring is worn on a user's finger and measures parameters such as heartbeat and blood oxygen level by directing light into the user's tissue. ¶72 col. 4:21-25
a software application associated with a control system for generating data representing physiological information... The Ōura app, provided by Ōura, runs on a smartphone or tablet and processes data from the ring. ¶71 col. 4:31-36
the control system having a touch-screen, voice and manual inputs capabilities... The control system is identified as an iOS or Android smartphone or tablet, which has touch-screen, voice, and manual input capabilities. ¶70; ¶74 col. 1:47-60
a host comprising a digital file for storing wireless data, control logic to process the wireless data... and an output for communicating a portion of the status... to one or more remotely located display output devices. The Ōura Cloud platform allegedly receives, processes, and stores the physiological data, functioning as the claimed "host." ¶71; ¶72 col. 1:63-2:13

9,651,533 Infringement Allegations

Claim Element (from Independent Claim 11) Alleged Infringing Functionality Complaint Citation Patent Citation
a light source comprising one or more light emitting diodes for generating an output optical beam...in the wavelength range of between 700 and 2500 nanometers... The Ōura Ring products use hardware components, including light sources, to measure physiological parameters. ¶72; ¶43 col. 26:28-36
a plurality of lenses receiving a portion of the output optical beam and delivering an analysis output beam to a sample... The Ōura Ring is worn on the finger and directs light into the user's tissue to make measurements. ¶72; ¶43 col. 26:37-39
a receiver to receive and process a portion of the analysis output beam reflected from the sample to generate an output signal... The Ōura Ring products contain hardware to detect reflected light and generate a signal representing physiological parameters. ¶72; ¶43 col. 26:40-44
a personal device configured to receive and process a portion of the output signal and to store and display the processed output signal... The Ōura app on an iOS or Android smartphone or tablet receives data from the ring for processing and display. ¶70; ¶72 col. 26:45-50
a remote device configured to receive a wirelessly transmitted output status... and to process the received output status. The Ōura Cloud platform receives data from the smartphone/tablet for further processing and storage. ¶71; ¶72 col. 26:51-56
  • Identified Points of Contention:
    • Scope Questions: A central dispute may arise over whether the combination of an Ōura Ring with a separate, third-party smartphone/tablet and a remote cloud server constitutes the claimed "system." The defense might argue that Ōura does not "make" or "use" the entire claimed system, particularly the smartphone which it does not manufacture. The plaintiff's theory appears to rely on the components being "designed and intended to be integrated into a complete system" Compl. ¶72
    • Technical Questions: The complaint broadly alleges that the Ōura Ring uses hardware and software to perform the claimed functions but does not provide deep technical specifics on how the accused product's signal processing works. This raises the evidentiary question of whether Ōura's methods for improving signal quality (if any) align with the specific techniques required by the claims of the '304 and '475 patents, such as differencing signals or specific detector synchronization.

V. Key Claim Terms for Construction

For U.S. Patent No. 9,055,868:

  • The Term: "control system"
  • Context and Importance: The infringement theory hinges on the "control system" being the user's smartphone or tablet Compl. ¶72 Compl. ¶74 The definition of this term is critical because if it is construed to require a single, integrated device manufactured by the defendant, the infringement case could be significantly weakened. Practitioners may focus on this term because it is the lynchpin connecting the accused ring to the separately-sold smartphone that provides the claimed input/output capabilities.
  • Intrinsic Evidence for Interpretation:
    • Evidence for a Broader Interpretation: The specification describes "a control system remote from an optical measurement device" and that "the control system may be a smart phone or tablet" '868 Patent, col. 1:47-49 '868 Patent, col. 4:32-33 This language may support an interpretation where the "control system" is a separate device, like a smartphone.
    • Evidence for a Narrower Interpretation: The claims recite the control system as "having" specific hardware like a "wireless transceiver" and "circuitry for obtaining position information." A defendant may argue that a general-purpose smartphone does not constitute the specific "control system" of the claim, but rather is a platform on which a software component runs, and that Ōura does not provide the entire claimed combination.

For U.S. Patent No. 9,651,533:

  • The Term: "personal device"
  • Context and Importance: Similar to "control system" in the '868 patent, the infringement allegation identifies the "personal device" as a smartphone or tablet Compl. ¶42 Compl. ¶78 Its construction will determine whether a standard consumer electronic device can satisfy this claim element as part of an infringing system.
  • Intrinsic Evidence for Interpretation:
    • Evidence for a Broader Interpretation: The specification explicitly states that a "smart phone or tablet" can serve as the personal device to receive, process, and display the signal, and transmit it to a remote device or "the cloud" '533 Patent, col. 5:54-6:3 Figure 13 also depicts a "SMART PHONE, TABLET, CELL PHONE, PDA, COMPUTER" as the intermediary device.
    • Evidence for a Narrower Interpretation: A defendant may argue that the claim requires a single party to provide the entire system. While the specification discloses using a smartphone, the defense could contend that merely providing an app for a third-party device does not constitute "making" or "selling" the claimed system, which includes the "personal device" itself.

VI. Other Allegations

  • Indirect Infringement: The complaint alleges inducement of infringement for the '533, '304, and '475 patents. The factual basis for this allegation is that Ōura manufactures, sells, and provides instructions for the Ōura Ring products, which are designed to operate with a smartphone and cloud platform in a manner that allegedly infringes Compl. ¶83 Compl. ¶95 Compl. ¶106 The complaint also alleges contributory infringement, stating the Ōura Ring and its software are material to the invention, especially made for use in an infringing system, and not a staple article of commerce Compl. ¶85 Compl. ¶97 Compl. ¶108
  • Willful Infringement: Willfulness is alleged for the '533, '304, and '475 patents. The complaint alleges pre-suit knowledge based on several grounds: Ōura's own U.S. Patent No. 12,013,725 allegedly identifies the '533 patent on its face Compl. ¶68; notice of the '868, '533, and '304 patents was allegedly provided via service of a complaint in a prior action Compl. ¶67; and notice for the '475 patent is alleged as of a specific date Compl. ¶104 These allegations suggest Ōura continued its alleged infringement despite knowledge of the patents.

VII. Analyst's Conclusion: Key Questions for the Case

  1. A central issue will be one of system-level infringement: Can Plaintiff prove that Ōura is liable for infringing "system" claims, where key components of the alleged infringing system (the smartphone/tablet) are manufactured and sold by third parties? The case may turn on whether Ōura's actions in providing the ring, app, and cloud platform constitute "making," "using," or "selling" the entire claimed system under U.S. patent law.

  2. A second core issue will be one of claim construction: How will the court define the terms "control system" ('868 patent) and "personal device" ('533 patent)? A broad construction encompassing general-purpose smartphones running an app would favor the plaintiff's infringement theory, while a narrower construction requiring a more integrated, single-source device could present a significant hurdle to proving infringement.

  3. A key question on damages will be one of willfulness: Does the evidence support the complaint's allegation that Ōura had pre-suit knowledge of the asserted patents, particularly the allegation that Ōura's own patent prosecution put it on notice of the '533 patent? A finding of willfulness could expose the defendant to the possibility of treble damages.

Loading Amended Complaint